Improvement of pharmacokinetic and antitumor activity of layered double hydroxide nanoparticles by coating with PEGylated phospholipid membrane

International Journal of Nanomedicine

Volumn 9, Issue , 2014, Pages 4867-4878

  Yan, Mina ^a,b   Zhang, Zhaoguo ^b   Cui, Shengmiao ^c   Lei, Ming ^b   Zeng, Ke ^b   Liao, Yunhui ^b   Chu, Weijing ^b   Deng, Yihui ^a   Zhao, Chunshun ^b  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Cancer therapy; Delivery system; Lipid membrane; Positive charge

Indexed keywords

ANTINEOPLASTIC AGENT; LAYERED DOUBLE HYDROXIDE; LIPOSOME; MACROGOL; METHOTREXATE; NANOPARTICLE; PHOSPHOLIPID; UNCLASSIFIED DRUG; DRUG CARRIER; HYDROXIDE; MACROGOL DERIVATIVE; PLASMA PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG CLEARANCE; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG STRUCTURE; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR TRANSPORT; LIPID MEMBRANE; NONHUMAN; PROTEIN INTERACTION; RAT; SURVIVAL RATE; TRANSMISSION ELECTRON MICROSCOPY; TUMOR GROWTH; X RAY PHOTOELECTRON SPECTROSCOPY; ANIMAL; BLOOD; BODY WEIGHT; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; HELA CELL LINE; HUMAN; MOUSE; PARTICLE SIZE; SPRAGUE DAWLEY RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD PROTEINS; BODY WEIGHT; CELL SURVIVAL; DRUG CARRIERS; HELA CELLS; HUMANS; HYDROXIDES; METHOTREXATE; MICE; NANOPARTICLES; PARTICLE SIZE; PHOSPHOLIPIDS; POLYETHYLENE GLYCOLS; RATS, SPRAGUE-DAWLEY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84916884716     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S69729     Document Type: Article

References (39)

1. Liu X, Fan B, Gao S, Li R. Transesterification of tributyrin with methanol over MgAl mixed oxides derived from MgAl hydrotalcites synthesized in the presence of glucose. Fuel Processing Technology. 2013; 106: 761-768.
2. Sels B, De Vos D, Buntinx M, Pierard F, Kirsch-De Mesmaeker A, Jacobs P. Layered double hydroxides exchanged with tungstate as biomimetic catalysts for mild oxidative bromination. Nature. 1999; 400: 855-857.
3. Drenkova-Tuhtan A, Mandel K, Paulus A, et al. Phosphate recovery from wastewater using engineered superparamagnetic particles modified with layered double hydroxide ion exchangers. Water Res. 2013; 47(15): 5670-5677.
4. Shin HS, Kim MJ, Nam SY, Moon HC. Phosphorus removal by hydrotalcite-like compounds (HTLcs). Water Sci Technol. 1996; 34(1-2): 161-168.
5. Jia C, Qian Y, Chen X, Liu Y. Flame retardant ethylene-vinyl acetate composites based on layered double hydroxides with zinc hydroxystannate. Polymer Engineering and Science. Epub 2014, Jan 22.
6. Zammarano M, Franceschi M, Bellayer S, Gilman JW, Meriani S. Preparation and flame resistance properties of revolutionary self-extinguishing epoxy nanocomposites based on layered double hydroxides. Polymer. 2005; 46(22): 9314-9328.
7. Ladewig K, Xu ZP, Lu GQ. Layered double hydroxide nanoparticles in gene and drug delivery. Expert Opin Drug Deliv. 2009; 6(9): 907-922.
8. Rives V, Del Arco M, Martín C. Layered double hydroxides as drug carriers and for controlled release of non-steroidal antiinflammatory drugs (NSAIDs): a review. J Control Release. 2013; 169(1-2): 28-39.
9. Seftel EM, Popovici E, Mertens M, et al. Zn-Al layered double hydroxides: synthesis, characterization and photocatalytic application. Microporous Mesoporous Mater. 2008; 113(1-3): 296-304.
10. Auerbach MS, Carrado KA, Dutta PK, editors. Handbook of Layered Materials. Boca Raton, FL: CRC Press; 2004.
11. Cavani F, Trifirò F, Vaccari A. Hydrotalcite-type anionic clays: preparation, properties and applications. Catal Today. 1991; 11(2): 173-301.
12. Xu ZP, Stevenson G, Lu CQ, Lu GQ. Dispersion and size control of layered double hydroxide nanoparticles in aqueous solutions. J Phys Chem B. 2006; 110(34): 16923-16929.
13. Choi SJ, Oh JM, Choy JH. Biocompatible nanoparticles intercalated with anticancer drug for target delivery: pharmacokinetic and biodistribution study. J Nanosci Nanotechnol. 2010; 10(4): 2913-2916.
14. Oh JM, Choi SJ, Kim ST, Choy JH. Cellular uptake mechanism of an inorganic nanovehicle and its drug conjugates: enhanced efficacy due to clathrin-mediated endocytosis. Bioconjug Chem. 2006; 17(6): 1411-1417.
15. Qin L, Xue M, Wang W, et al. The in vitro and in vivo anti-tumor effect of layered double hydroxides nanoparticles as delivery for podophyllotoxin. Int J Pharm. 2010; 388(1-2): 223-230.
16. Xue YH, Zhang R, Sun XY, Wang SL. The construction and characterization of layered double hydroxides as delivery vehicles for podophyllotoxins. J Mater Sci Mater Med. 2008; 19(3): 1197-1202.
17. Ladewig K, Niebert M, Xu ZP, Gray PP, Lu GQ. Efficient siRNA delivery to mammalian cells using layered double hydroxide nanoparticles. Biomaterials. 2010; 31(7): 1821-1829.
18. Ladewig K, Niebert M, Xu ZP, Gray PP, Lu GQ. Controlled preparation of layered double hydroxide nanoparticles and their application as gene delivery vehicles. Appl Clay Sci. 2010; 48(1-2): 280-289.
19. Li B, Wu P, Ruan B, Liu P, Zhu N. Study on the adsorption of DNA on the layered double hydroxides (LDHs). Spectrochim Acta A Mol Biomol Spectrosc. 2014; 121: 387-393.
20. Wong Y, Markham K, Xu ZP, et al. Efficient delivery of siRNA to cortical neurons using layered double hydroxide nanoparticles. Biomaterials. 2010; 31(33): 8770-8779.
21. Oh JM, Choi SJ, Lee GE, Kim JE, Choy JH. Inorganic metal hydroxide nanoparticles for targeted cellular uptake through clathrin-mediated endocytosis. Chem Asian J. 2009; 4(1): 67-73.
22. Xu ZP, Niebert M, Porazik K, et al. Subcellular compartment targeting of layered double hydroxide nanoparticles. J Control Release. 2008; 130(1): 86-94.
23. Chung HE, Park DH, Choy JH, Choi SJ. Intracellular trafficking pathway of layered double hydroxide nanoparticles in human cells: size-dependent cellular delivery. Appl Clay Sci. 2012; 65-66: 24-30.
24. Taratula O, Garbuzenko OB, Kirkpatrick P, et al. Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery. J Control Release. 2009; 140(3): 284-293.
25. Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm. 2008; 5(4): 505-515.
26. Kakizawa Y, Furukawa S, Ishii A, Kataoka K. Organic-inorganic hybrid-nanocarrier of siRNA constructing through the self-assembly of calcium phosphate and PEG-based block aniomer. J Control Release. 2006; 111(3): 368-370.
27. Schmidt HT, Gray BL, Wingert PA, Ostafin AE. Assembly of aqueous-cored calcium phosphate nanoparticles for drug delivery. Chem Mater. 2004; 16(24): 4942-4947.
28. Hadinoto K, Sundaresan A, Cheow WS. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Eur J Pharm Biopharm. 2013; 85(3 Pt A): 427-443.
29. Xu ZP, Jin Y, Liu S, Hao ZP, Lu GQ. Surface charging of layered double hydroxides during dynamic interactions of anions at the interfaces. J Colloid Interface Sci. 2008; 326(2): 522-529.
30. Hunter RH. Zeta potential in colloid science. New York: Academic Press, 1981.
31. Guo H, Zhang D, Li C, et al. Self-assembled nanoparticles based on galactosylated O-carboxymethyl chitosan-graft-stearic acid conjugates for delivery of doxorubicin. Int J Pharm. 2013; 458(1): 31-38.
32. Zhang J, Dong G, Thurber A, et al. Tuning the properties of ZnO, hematite, and Ag nanoparticles by adjusting the surface charge. Adv Mater. 2012; 24(9): 1232-1237.
33. Layre A, Couvreur P, Chacun H, et al. Novel composite core-shell nanoparticles as busulfan carriers. J Control Release. 2006; 111(3): 271-280.
34. Bowey K, Tanguay JF, Tabrizian M. 2-Dioleoyl-sn-glycero-3-phosphocholine-based nanoliposomes as an effective delivery platform for 17β-estradiol. Eur J Pharm Biopharm. 2014; 86(3): 369-375.
35. Yu Z, Schmaltz RM, Bozeman TC, et al. Selective tumor cell targeting by the disaccharide moiety of bleomycin. J Am Chem Soc. 2013; 135(8): 2883-2886.
36. Naguib YW, Cui Z. Nanomedicine: The promise and challenges in cancer chemotherapy. In: Capco DG, Chen Y, editors. Nanomaterial: Impacts on Cell Biology and Medicine. Dordrecht: Springer Netherlands; 2014: 207-233.
37. Sabharanjak S, Mayor S. Folate receptor endocytosis and trafficking. Adv Drug Deliv Rev. 2004; 56(8): 1099-1109.
38. Zhao R, Gao F, Hanscom M, Goldman ID. A prominent low-pH methotrexate transport activity in human solid tumors: contribution to the preservation of methotrexate pharmacologic activity in HeLa cells lacking the reduced folate carrier. Clin Cancer Res. 2004; 10(2): 718-727.
39. Taratula O, Dani RK, Schumann C, et al. Multifunctional nanomedicine platform for concurrent delivery of chemotherapeutic drugs and mild hyperthermia to ovarian cancer cells. Int J Pharm. 2013; 458(1): 169-180.